Antisense modulation of pctaire protein kinase 2 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorAndrew T. Watt
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of PCTAIRE protein kinase 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PCTAIRE protein kinase 2. Methods of using these compounds for modulation of PCTAIRE protein kinase 2 expression and for treatment of diseases associated with expression of PCTAIRE protein kinase 2 are provided.
Claims11
An antisense oligonucleotide 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding PCTAIRE protein kinase 2, wherein said antisense oligonucleotide specifically hybridizes with said nucleic acid molecule encoding PCTAIRE protein kinase 2 and has a sequence comprising SEQ ID NO:
- 14, 15, 16, 18, 19, 20, 21, 26, 29, 30, 31, 32, 33, 36, 37, 38, 39, 40, 41, 42, 43, 44, 46, 49, 50, 54, 55, 57, 58, 59, 60, 61, 62, 63, 65, 66, 68, 69, 70, 71, 75, 76, 78, 79, 80, 84, 85, 86, 89 or 91.
A compound 8 to 80 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of a preferred target region on a nucleic acid molecule encoding PCTAIRE protein kinase 2.
Dependencies are inferred from the claim text.